ProCE Banner Activity

The Role of Pharmacists in Optimizing Treatment for Patients With Chronic Lymphocytic Leukemia

Clinical Thought

Commentary by Karen M. Fancher, PharmD, BCOP, discussing considerations for optimal therapy for individual patients with CLL/SLL and how pharmacists can support patients to improve treatment outcomes.

Released: July 31, 2023

Share

Faculty

Karen M. Fancher

Karen M. Fancher, PharmD, BCOP

Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist, Oncology
University of Pittsburgh Medical Center Passavant
Pittsburgh, Pennsylvania

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and BeiGene.

AstraZeneca

BeiGene

Partners

Clinical Care Options, LLC

ProCE Banner

Disclosure

Primary Author

Karen M. Fancher, PharmD, BCOP

Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist, Oncology
University of Pittsburgh Medical Center Passavant
Pittsburgh, Pennsylvania

Karen M. Fancher, PharmD, BCOP: consultant/advisor/speaker: AstraZeneca, BTG Specialty Pharmaceuticals, G1 Therapeutics.